browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
7f2a2d5b-0d12-4ff0-ba0a-e6dc75de9ba5
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 20:43:08
Income (reported)
—
Expenses (reported)
$590,000
Expenses method
A
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

ASTELLAS PHARMA US, INC.

Pharmaceuticals

Contact
CHRISTINE BLOOMQUIST
Phone
+1 571-471-9064
Address
zip:60062, city:Northbrook, state:IL, street:2375 Waterview Drive

Client

ASTELLAS PHARMA US, INC.

State
IL
Country
US
Government-entity client
false
Effective date
2018-05-17

Issues lobbied + lobbyists

MMM — Medicare/Medicaid

Issues pertaining to Medicare Part D; H.R. 1300/S. 297 PSA screening bills; Issues related to the Inflation Reduction Act (Pub. L. 117-169); Issues related to OBBA (Pub. L. No: 119-21).

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

H.R. 1300/S. 297, PSA screening bills; Issues related to Women's Health and Menopause (no specific bills); Issues related to Eye Screening and Access (no specific bills); Issues related to implementation of the Inflation Reduction Act (Pub. L. 117-169); Issues Related to OBBA (Pub. L. No: 119-21); Issues related to health care transparency.

Lobbyists:

Government entities lobbied: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

CPT — Copyright/Patent/Trademark

Issues related to IP/Bayh-Dole Act (Pub.L. 96-517).

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

Issues related to OBBA (Pub. L. No: 119-21).

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.